Abstract:Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre supplementation on gut microbiome composition and short-chain fatty acid (SCFA) production. We then investigated how changes in gut microbiome composition correlated with changes in traditional cardiovascular risk factors (cholesterol, triglycerides, blood pressure), cytokines, and novel validated markers such as GlycA and ceramides, previously linked to CVD incidence and mortality. Both interventions resulted in significant drops in blood pressure, cholesterol, proinflammatory cytokines, GlycA and ceramides (all P < 0.05). Decreases in the atherogenic low-density lipoprotein triglyceride fraction, in total serum cholesterol were correlated with increases in butyric acid-production [β(SE) = -0.58 (0.06), P < 0.001; -0.53 (0.04), P < 0.001] and nominally associated with increases in some butyrogenic bacteria. Drops in GlycA were linked to increases in Bifidobacterium [β(SE) = -0.32 (0.04), P = 0.02] and other SCFAs including acetic acid [β(SE) = -0.28 (0.04), P = 0.02] and propionic acid [β(SE) = -0.3 (0.04), P = 0.02]. Additionally, we report for the first-time reductions in specific ceramide ratios that have been shown to predict CVD mortality and major adverse cardiovascular events such as d18:1/16:0, d18:0/24:0, and d18:1/24:1 which were associated with the reduction in the abundance in Colinsella and increases in Bifidobacteriuim and Coprococcus 3 and SCFAs (all P < 0.05). Conclusion: Overall, these findings support the potential of using simple dietary interventions to alter validated biomarkers linked to cardiovascular risk via the gut microbiome composition and its metabolic functions.

Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review

Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

Gut microbiome and cardiometabolic risk

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health

Gut microbiota and health: connecting actors across the metabolic system

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis

Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension

Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease

Influence of diet on the gut microbiome and implications for human health

A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease.

Gut microbiota derived short-chain fatty acids in physiology and pathology: An update

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

Short‐chain fatty acids: bridges between diet, gut microbiota, and health

From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?

The Metabolic Role and Therapeutic Potential of the Microbiome

Diet-gut microbiota interactions on cardiovascular disease

Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology

Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites